Perforomist and Hypersensitivity - a phase IV clinical study of FDA data

Summary:

Hypersensitivity is reported as a side effect among people who take Perforomist (formoterol fumarate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Meclizine, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Hypersensitivity when taking Perforomist. It is created by eHealthMe based on reports of 1,410 people who have side effects when taking Perforomist from the FDA, and is updated regularly.

What is Perforomist?

Perforomist has active ingredients of formoterol fumarate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 1,431 Perforomist users. Check the latest studies of Perforomist.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,748 drugs and 2,916 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

1,410 people reported to have side effects when taking Perforomist.
Among them, 35 people (2.48%) have Hypersensitivity.

Could Perforomist cause Hypersensitivity?

Among these 35 people:

How long have people been on Perforomist when they have Hypersensitivity? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Hypersensitivity when taking Perforomist? *

  • female: 85.71 %
  • male: 14.29 %

What is the age of people who have Hypersensitivity when taking Perforomist? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 31.82 %
  • 50-59: 18.18 %
  • 60+: 50.0 %

What are other drugs people take besides Perforomist? *

  1. Meclizine: 15 people, 42.86%
  2. Singulair: 14 people, 40.00%
  3. Metformin: 12 people, 34.29%
  4. Aspirin: 12 people, 34.29%
  5. Albuterol: 11 people, 31.43%
  6. Triamcinolone: 10 people, 28.57%
  7. Epinephrine: 10 people, 28.57%
  8. Lidocaine: 10 people, 28.57%
  9. Melatonin: 10 people, 28.57%
  10. Metformin Hydrochloride: 10 people, 28.57%

What are other side effects people have besides Hypersensitivity? *

  1. Fatigue (feeling of tiredness): 11 people, 31.43%
  2. Heart Palpitations (feelings or sensations that your heart is pounding or racing): 9 people, 25.71%
  3. Staphylococcal Infection (an infection with staphylococcus bacteria): 8 people, 22.86%
  4. Infusion Related Reaction: 8 people, 22.86%
  5. Parainfluenzae Virus Infection: 7 people, 20.00%
  6. Infusion Site Erythema (reddening of the skin at infusion site): 7 people, 20.00%
  7. Infection: 7 people, 20.00%
  8. Herpes Zoster: 7 people, 20.00%
  9. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 7 people, 20.00%
  10. Respiratory Disorder (respiratory disease): 7 people, 20.00%

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 15 people, 42.86%
  2. Asthma: 9 people, 25.71%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 22.86%
  4. Primary Immunodeficiency Syndrome: 7 people, 20.00%
  5. Migraine (headache): 4 people, 11.43%
  6. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 4 people, 11.43%
  7. Burkholderia Mallei Infection (infection caused by group of bacteria burkholderia mallei): 2 people, 5.71%
  8. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 2 people, 5.71%
  9. Dyspnea (difficult or laboured breathing): 2 people, 5.71%
  10. Immune System Disorder: 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Perforomist and have Hypersensitivity?

- Check whether Hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Perforomist:

Hypersensitivity treatments and more:

How severe was Hypersensitivity and when was it recovered:

Expand to all the drugs that have ingredients of formoterol fumarate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Perforomist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypersensitivity:

Browse all the conditions that are associated with Hypersensitivity:


How the study uses the data?

The study uses data from the FDA. It is based on formoterol fumarate (the active ingredients of Perforomist) and Perforomist (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: